Abstract:Graft arteriosclerois (GA), also called allograft vasculopathy, is a pathologic lesion that develops over months to years in transplanted organs characterized by diffuse, circumferential stenosis of the entire graft vascular tree. The most critical component of GA pathogenesis is the proliferation of smooth muscle-like cells within the intima. When a human coronary artery segment is interposed into the infra-renal aortae of immunodeficient mice, the intimas could be expand in response to adoptively transferred human T cells allogeneic to the artery donor or exogenous human IFN-γ in the absence of human T cells. Interposition of a mouse aorta from one strain into another mouse strain recipient is limited as a model for chronic rejection in humans because the acute cell-mediated rejection response in this mouse model completely eliminates all donor-derived vascular cells from the graft within two-three weeks. We have recently developed two new mouse models to circumvent these problems. The first model involves interposition of a vessel segment from a male mouse into a female recipient of the same inbred strain (C57BL/6J). Graft rejection in this case is directed only against minor histocompatibility antigens encoded by the Y chromosome (present in the male but not the female) and the rejection response that ensues is sufficiently indolent to preserve donor-derived smooth muscle cells for several weeks. The second model involves interposing an artery segment from a wild type C57BL/6J mouse donor into a host mouse of the same strain and gender that lacks the receptor for IFN-γ followed by administration of mouse IFN-γ (delivered via infection of the mouse liver with an adenoviral vector. There is no rejection in this case as both donor and recipient mice are of the same strain and gender but donor smooth muscle cells proliferate in response to the cytokine while host-derived cells, lacking receptor for this cytokine, are unresponsive. By backcrossing additional genetic changes into the vessel donor, both models can be used to assess the effect of specific genes on GA progression. Here, we describe detailed protocols for our mouse GA models.

Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunction

Mouse Heterotopic Abdominal Heart Transplant Model

Introduction of Modified Cervical Cardiac Transplant Model in Mice.

A Novel and Knotless Technique for Heterotopic Cardiac Transplantation in Mice

Strategies for Successfully Establishing A Kidney Transplant in A Mouse Model

Mouse Models for Graft Arteriosclerosis.

A Simple Cuff Technique for Murine Left Lung Transplantation

A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation

The Immunopathology of Pulmonary Rejection after Murine Lung Transplantation

The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

Advancing mouse models for transplantation research

A Novel MyD88 Inhibitor Attenuates Allograft Rejection after Heterotopic Tracheal Transplantation in Mice

Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation

Organ Transplantation in Rodents: Novel Applications of Long-Established Methods

Pig lung transplant survival model

Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction

Induction of Chronic Renal Allograft Dysfunction in a Rat Model with Complete and Exclusive MHC Incompatibility

A Review of Various Techniques of Mouse Liver Transplantation

Animal models for transplant immunology: bridging bench to bedside

Orthotopic Tracheal Transplantation in the Murine Model1